Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
Clinical trial NCT01897454 · TERMINATED
Trial details
- NCT number
- NCT01897454
- Sponsor
- Albert Einstein College of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-27
- Primary completion
- 2021-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.